How G-SPECT can help address 99Mo availability issues

To ensure availability of sufficient amounts of 99Mo for diagnostic imaging, the US Government announced plans for a new production facility in Janesville (WI) [1]. With the recent development of MILabs’ super-resolution G-SPECT* for large animal and human imaging, reduction of 99Mo may be possible. Indeed, this new system enables to cut 99mTc patient doses up to ten-fold with high accuracy while still scanning faster than ever before.

Game-changing performance with gyro-free SPECT:

  • Industry’s finest volumetric SPECT resolution: with a ten-fold volumetric resolution improvement over current state-of-the-art SPECT systems [2], G-SPECT* is designed to provide quality images equal to the best clinical PET systems.
  • Lower 99mTc consumption: thanks to the breakthrough full-ring, gyro-free detector technology, G-SPECT* enables to reduce tracer doses by up to ten times.

Demonstration of G-SPECT’s image quality improvement using the Alderson brain phantom for DaTscan images from different cameras, at shorter imaging times and with a five-fold reduction in dose [2, 3].

  1. Inside the Global Relay Race to Deliver Moly-99. The New York Times. Jan 12, 2018
  2. G-SPECT: a full ring high sensitivity and ultra-fast clinical molecular imaging system with <3 mm resolution. Beekman F.J. et al. Eur J Nucl Med Mol Imaging. 2015;42 Suppl 1:S209
  3. Adapted from “Variation of DaTSCAN Quantification Between Different Gamma Camera Types”., R.J. Morton et al. Nucl. Med. Commun. 2005

* G-SPECT is not available for clinical use, yet. Sale for such use depends on local (pre)market approval, including FDA and CE certifications.

Scroll to Top